Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.

dc.contributor.author

Kuan, Chien-Tsun

dc.contributor.author

Wikstrand, Carol J

dc.contributor.author

McLendon, Roger E

dc.contributor.author

Zalutsky, Michael R

dc.contributor.author

Kumar, Ujendra

dc.contributor.author

Bigner, Darell D

dc.coverage.spatial

United States

dc.date.accessioned

2011-04-15T16:46:29Z

dc.date.issued

2009-12

dc.description.abstract

Somatostatin receptor 2 (SSTR2) is expressed by most medulloblastomas (MEDs). We isolated monoclonal antibodies (MAbs) to the 12-mer (33)QTEPYYDLTSNA(44), which resides in the extracellular domain of the SSTR2 amino terminus, screened the peptide-bound MAbs by fluorescence microassay on D341 and D283 MED cells, and demonstrated homogeneous cell-surface binding, indicating that all cells expressed cell surface-detectable epitopes. Five radiolabeled MAbs were tested for immunoreactive fraction (IRF), affinity (KA) (Scatchard analysis vs. D341 MED cells), and internalization by MED cells. One IgG(3) MAb exhibited a 50-100% IRF, but low KA. Four IgG(2a) MAbs had 46-94% IRFs and modest KAs versus intact cells (0.21-1.2 x 10(8) M(-1)). Following binding of radiolabeled MAbs to D341 MED at 4 degrees C, no significant internalization was observed, which is consistent with results obtained in the absence of ligand. However, all MAbs exhibited long-term association with the cells; binding at 37 degrees C after 2 h was 65-66%, and after 24 h, 52-64%. In tests with MAbs C10 and H5, the number of cell surface receptors per cell, estimated by Scatchard and quantitative FACS analyses, was 3.9 x 10(4) for the "glial" phenotype DAOY MED cell line and 0.6-8.8 x 10(5) for four neuronal phenotype MED cell lines. Our results indicate a potential immunotherapeutic application for these MAbs.

dc.description.version

Version of Record

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/20025498

dc.identifier.eissn

1557-8348

dc.identifier.uri

https://hdl.handle.net/10161/3241

dc.language

eng

dc.language.iso

en_US

dc.publisher

Mary Ann Liebert Inc

dc.relation.ispartof

Hybridoma (Larchmt)

dc.relation.isversionof

10.1089/hyb.2009.0049

dc.relation.journal

Hybridoma

dc.subject

Amino Acid Sequence

dc.subject

Antibodies, Monoclonal

dc.subject

Blotting, Western

dc.subject

Cell Line, Tumor

dc.subject

DNA Primers

dc.subject

Enzyme-Linked Immunosorbent Assay

dc.subject

Flow Cytometry

dc.subject

Humans

dc.subject

Immunohistochemistry

dc.subject

Immunotherapy

dc.subject

Medulloblastoma

dc.subject

Protein Structure, Tertiary

dc.subject

Receptors, Somatostatin

dc.subject

Reverse Transcriptase Polymerase Chain Reaction

dc.title

Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.

dc.type

Journal article

duke.contributor.orcid

McLendon, Roger E|0000-0001-6682-4588

duke.contributor.orcid

Zalutsky, Michael R|0000-0002-5456-0324

duke.contributor.orcid

Bigner, Darell D|0000-0001-5548-4899

duke.date.pubdate

2009-12-0

duke.description.issue

6

duke.description.volume

28

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/20025498

pubs.begin-page

389

pubs.end-page

403

pubs.issue

6

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Neurosurgery

pubs.organisational-group

Pathology

pubs.organisational-group

Radiation Oncology

pubs.organisational-group

Radiology

pubs.organisational-group

School of Medicine

pubs.organisational-group

Surgery

pubs.publication-status

Published

pubs.volume

28

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
272955100001.pdf
Size:
550.94 KB
Format:
Adobe Portable Document Format